The Algerian public pharmaceutical group SAIDAL achieved a record turnover of 44.04 billion Algerian dinars in 2025, equivalent to around $326 million, an increase of 98.43% compared to the previous year. These results were presented at the general assembly held on June 29, 2026. This growth is explained by an increase in sales. The group…...
Trending
- Banks: Coris Bank International’s net banking income increases by 29% in the first quarter of 2026
- Banks: 39.8 million bank accounts opened by the end of 2025 in Morocco
- Nouakchott, African capital of health investment
- The Kinshasa Stock Exchange: a decisive opportunity for the DRC — and for economic relations between the United States and Africa
- Senegal: Social tension rises at Senelec over a performance bonus
- Review of decisions taken during the second session of the Council of Ministers of the West African Economic and Monetary Union (WAEMU): debt, financial stability, and social protection at the heart of priorities
- Bouboulou Gold Mine: Burkinabe State to Invest 32 Billion CFA for Expected 39 Billion Revenue
- Senegal: Who will restructure the debt?
